Orchestra BioMed Holdings Inc (OBIO) USD0.0001
Sell:$2.64Buy:$2.77
$0.20
(7.75%)
- This stock can be held in a
Stocks and Shares ISA$0.20
(7.75%)$0.20
(7.75%)Company Information
About this company
Orchestra BioMed Holdings, Inc. is a biomedical innovation company. The Company’s lead product candidates include Atrioventricular Interval Modulation (AVIM) therapy for the treatment of hypertension (HTN), the leading risk factor for death worldwide and the Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the leading cause of mortality worldwide. The Company develops bioelectronic therapies based on patented Cardiac Neuromodulation Therapy (CNT) technology. The AVIM is a bioelectronic therapy candidate designed to substantially and persistently lower blood pressure. Its Virtue SAB is a proprietary drug/device combination product candidate for the treatment of artery disease that is designed to deliver a proprietary, investigational, extended-release formulation of sirolimus (SirolimusEFR) to the vessel wall during balloon angioplasty without the need for balloon coating or a permanent implant.
Key people
Key facts
- EPICOBIO
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- ISINUS68572M1062
- Market cap$109.19m
- Employees70
- Shares in issue38.31m
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.